Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review
Open Access
- 1 July 2005
- Vol. 60 (7), 588-594
- https://doi.org/10.1136/thx.2004.035220
Abstract
Background: Idiopathic pulmonary fibrosis (IPF) profoundly affects the quality of patientsâ lives. A systematic review was performed to evaluate critically the published literature and to examine what is known about health-related quality of life (HRQL) in patients with IPF. Methods: The MEDLINE, EMBASE, Health and Psychosocial Instruments, and Cochrane Library databases were searched to 1 April 2004. Abstracts and bibliographies of published articles were scanned and contact was made with investigators. Included studies analysed HRQL (or quality of life) in at least 10 patients with IPF. Two reviewers independently selected studies, evaluated their quality according to predetermined criteria, and abstracted data on study design, patientsâ demographic and clinical characteristics, and quality of life outcome measures. Results: Seven studies met the inclusion criteria. The studies enrolled 512 patients with IPF and used three different instruments to measure HRQL. All studies had important limitations in methodological quality; none measured longitudinal changes in HRQL over time. Patients reported substantially impaired HRQL, especially in domains that measured physical health and level of independence. Patients with IPF appear to have similar impairments in HRQL to those with chronic obstructive pulmonary disease. Measures of dyspnoea were moderately correlated with scores from domains that measured physical health (R2 = 0.03â0.66) and energy/fatigue/pep (R2 = 0.19â0.55), but measures of pulmonary function and gas exchange did not correlate as strongly with these and other domains. Conclusion: Studies of HRQL in patients with IPF suggest that, in addition to the obvious effect on physical health, general health, energy level, respiratory symptoms, and level of independence are also impaired. Variability in HRQL among patients is not fully explained by measures of dyspnoea or pulmonary function, suggesting that HRQL measures provide unique information. More research is needed to identify or design appropriate measurement instruments for patients with IPF and to examine changes in HRQL over time or in response to specific treatments.Keywords
This publication has 24 references indexed in Scilit:
- Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2005
- Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?Respiratory Medicine, 2005
- A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2004
- A Randomized Trial Comparing Lung-VolumeâReduction Surgery with Medical Therapy for Severe EmphysemaNew England Journal of Medicine, 2003
- Health related quality of life in prostate carcinoma patientsCancer, 2003
- A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitisThorax, 2001
- Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survivalââAccess the âJournal Clubâ discussion of this paper at http://www.elsevier.com/locate/ajmselect/American Journal Of Medicine, 2001
- Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used?Respiratory Medicine, 2000
- Individual-patient monitoring in clinical practice: are available health status surveys adequate?Quality of Life Research, 1995
- Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease.Thorax, 1994